Evidence map›Paper›PMID 30305145›Full record

ArticleBMC research notes2018

Poliovirus excretion following vaccination with live poliovirus vaccine in patients with primary immunodeficiency disorders: clinicians' perspectives in the endgame plan for polio eradication.

Nermeen M Galal, Safaa Meshaal, Rabab ElHawary, Eman Nasr, Laila Bassiouni, Humayun Ashghar, Noha H Farag, Ondrej Mach, Cara Burns, Jane Iber and 2 more

Open access · goldAbstract read
In one paragraph

Article in BMC research notes, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Observational
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Whole-exome sequencing of TClinical and experimental immunology · 2021
    Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 3 countries.

Nermeen M GalalDepartment of Pediatrics, Cairo University, Cairo University Specialized Pediatric Hospital, 1 Ali Ibrahim Street, Mounira, Cairo, Egypt. nermeengalal@gmail.com.
Safaa MeshaalDepartment of Clinical and Chemical Pathology, Cairo University, 2 Ali Ibrahim Street, Kasr Alainy, Cairo, 11956, Egypt.
Rabab ElHawaryDepartment of Clinical and Chemical Pathology, Cairo University, 2 Ali Ibrahim Street, Kasr Alainy, Cairo, 11956, Egypt.
Eman NasrHolding Company for Biological Products and Vaccines, VACSERA, Regional Reference Polio Laboratory, 51 Wezaret ElZeraa, Al Agouzah, Dokki, Giza, 22311, Egypt.
Laila BassiouniHolding Company for Biological Products and Vaccines, VACSERA, Regional Reference Polio Laboratory, 51 Wezaret ElZeraa, Al Agouzah, Dokki, Giza, 22311, Egypt.
Humayun AshgharWorld Health Organization, EMRO and HQ, Avenue Appia 20, 1202, Geneva, Switzerland.
Noha H FaragCenters for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA, 30333, USA.
Ondrej MachWorld Health Organization, EMRO and HQ, Avenue Appia 20, 1202, Geneva, Switzerland.
Cara BurnsCenters for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA, 30333, USA.
Jane IberCenters for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA, 30333, USA.
Qi ChenCenters for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA, 30333, USA.
Aisha ElMarsafyDepartment of Pediatrics, Cairo University, Cairo University Specialized Pediatric Hospital, 1 Ali Ibrahim Street, Mounira, Cairo, Egypt.
Cairo University · EGCenters for Disease Control and Prevention · USWorld Health Organization · CH

Funding

World Health Organization 001
6 · The paper itself

Abstract

objectivePrimary immunodeficiency (PID) patients are prone to developing viral infections and should not be vaccinated with live vaccines. In such patients, prolonged excretion and viral divergence may occur and they may subsequently act as reservoirs in the community introducing mutated virus and jeopardizing polio eradication. One hundred and thirty PID cases were included for poliovirus detection in stool with assessment of divergence of detected polioviruses from oral polio vaccine (OPV) virus. Clinical presentations of PID patients with detectable poliovirus in stool specimens are described.

resultsSix PID patients (4.5%) had detectable vaccine-derived poliovirus (VDPV) excretion in stool specimens; of these, five patients had severe combined immunodeficiency (two with acute flaccid paralysis, one with meningoencephalitis and two without neurological manifestations), and one patient had X-linked agammaglobulinemia (paralysis developed shortly after diagnosis of immunodeficiency). All six case-patients received trivalent OPV. Five case-patients had type 2 immunodeficiency-related vaccine-derived polioviruses (iVDPV2) excretion; one had concomitant excretion of Sabin like type 3 virus and one was identified as iVDPV1 excretor. Surveillance for poliovirus excretion among PID patients is critical as these patients represent a potential source to reseed polioviruses into populations.

Indexed as

Virus SheddingCarrier StateDisease EradicationEgyptFecesFemaleHumansImmunologic Deficiency SyndromesInfantMalePoliomyelitisPoliovirusPoliovirus Vaccine, OralPublic Health SurveillanceVaccinationPoliovirus Vaccine, OralImmunodeficiencyPolio eradicationVirus excretion

Identifiers

PMID30305145
PMCPMC6180599
OpenAlexW2897069220

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.